A biopharmaceutical company is suing the Drug Enforcement Administration (DEA) over what it called unjustified delays to its application to
News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has
Cannabis rescheduling will now likely be delayed until next year as the US Drug Enforcement Administration (DEA) confirmed its plans
Analysis of the 42,000 public comments submitted to the Drug Enforcement Administration (DEA) regarding cannabis rescheduling shows ‘overwhelming support’ for
The deadline for public comments on the proposed rescheduling of cannabis in the US has now passed, with the Drug
The US Drug Enforcement Administration (DEA) has recieved over 30,000 comments on the planned cannabis rescheduling since opening up for
Former Drug Enforcement Agency (DEA) leaders and Republican state attorney generals have called for a public hearing on plans to
The Drug Enforcement Agency’s (DEA) Administrator, Anne Milgram, has come under fire from GOP congressmen over the apparent divergence of
The Drug Enforcement Administration (DEA) published its formal proposal for cannabis rescheduling, officially putting what is set to be the
Cannabis rescheduling in the US, a landmark legislative move that has held the attention of the global cannabis industry since
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
